Adicet Bio, Inc. (NASDAQ:ACET – Get Rating) has earned an average rating of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average twelve-month target price among […]